Disease Pathway Detection

Early research advances field of proteasome biology

Published in TB and Outbreaks Week, January 6th, 2004

Millennium Pharmaceuticals, Inc., (MLNM) and collaborators released findings that implicate the proteasome pathway in tuberculosis and extend the understanding of the pathway in stroke, advancing the field of proteasome biology.

"Some of the most advanced medical research today involves understanding the pathways of disease, and we strongly believe that the proteasome pathway plays a role in a number of critical diseases," said Robert I. Tepper, MD, president of research and development at Millennium. "This research provides avenues of interest that may lead to new treatment strategies for infectious disease as well as damaging vascular inflammation."

...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of TB and Outbreaks Week

Source: TB and Outbreaks Week (2004-01-06)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry